JAK1 and lung cancer: To determine whether JAK1,2/STAT3 pathway is associated with EMT and metastatic potential of lung cancer cells, we treat A549cisR and H157cisR cells with JAK inhibitor1 and stattic, respectively, and found that abilities of invasion were reduced (Fig. 5h).